Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05637983

Ultrasound-guided Femoral Puncture to Reduce Access- Related Complications After TAVR: (ACCESS-TAVR SIRIO)

Conditions: Transcatheter Aortic Valve Replacement

Sex: All
Ages: 18 Years – N/A
Phase: NA
Enrollment: 508
Sponsor: Fondazione Toscana Gabriele Monasterio

Location: Italy

Summary

Recent observational data showed a marked reduction of vascular and bleeding complications by the use of ultrasound(US)-guided femoral artery puncture to gain the vascular access and guide the implantation of the Perclose ProGlide® vascular closure system.We aimed to compare in a 1:1 randomized fashion the effect of US-guided femoral puncture and Perclose ProGlide® implantation optimization vs fluoroscopy-guided puncture followed by Perclose ProGlide/ ProStyle implantation (standard approach) during TAVR.

Eligibility Criteria

Inclusion Criteria:Eligible Patients are male or female with severe aortic stenosis evaluated by the Heart Team as candidate to TAVR based on the current cardiology guidelines.Exclusion Criteria:Refusal to participate in the study;Inability to provide written consent to the study protocol;Chronic immuno-suppressant therapy;Any concomitant condition which, in the opinion of the Investigator, would not allow safe participation in the study (e.g., drug addiction, alcohol abuse, emotional/psychological disorder);Enrolment in another study that could confound the results of this study;Life expectancy < 1 year;Any contraindication to TAVR procedure;Non transfemoral TAVR.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05637983). StuddyBuddy aggregates publicly available trial information.